Chapter 9: Advanced Molecular Analysis with ML
Synopsis
Author
Dr. Sridhar Babu Gummadi,
Professor and Principal, Department of Pharmaceutical Chemistry,
Sri Shivani College of Pharmacy, Warangal, Telangana, India
Abstract
The elucidation of molecular structure and function has been revolutionized by Deep Learning, particularly in solving the decades-old protein folding problem. This section details how advanced architectures like AlphaFold and RoseTTAFold utilize evolutionary co-variation and geometric constraints to predict 3D protein structures from 1D amino acid sequences with near-experimental accuracy. This capability accelerates drug design by enabling the virtual docking of small molecules to previously "undruggable" targets and facilitates the rational engineering of enzymes for industrial applications. Beyond proteins, machine learning is instrumental in illuminating the "dark matter" of the genome the vast array of non-coding RNAs (ncRNAs) that regulate gene expression. Computational models integrate sequence motifs and thermodynamic folding predictions to identify genes encoding microRNAs and long non-coding RNAs, distinguishing true functional elements from transcriptional noise. Furthermore, AI algorithms predict the functional targets of these regulatory molecules, constructing complex RNA-protein interaction networks that govern cellular differentiation and disease states. These computational advances provide a holistic view of molecular biology, moving from the static linear code of the genome to the dynamic, three-dimensional reality of the proteome and the intricate regulatory networks of the transcriptome.
Keywords: Protein Folding (AlphaFold), Structure-Based Drug Design, Non-Coding RNA (ncRNA), Deep Learning, Structural Homology, Evolutionary Co-variation
. 